UN program inks Moderna deal on 500M doses, starting in Q4
3 years, 8 months ago

UN program inks Moderna deal on 500M doses, starting in Q4

Associated Press  

GENEVA — U.S. biotech company Moderna will provide up to 500 million doses for the U.N.-backed program to ship coronavirus vaccines to needy people in low- and middle-income countries, but shipments won’t begin until the fourth quarter, the company and program leaders said Monday. Also Monday, the alliance announced that Sweden’s government has committed to donate 1 million doses of the Oxford-AstraZeneca vaccine “to help COVAX urgently address immediate-term supply delays.” Moderna has already struck, and been delivering on, supply agreements with many rich countries, which have received millions of doses of its vaccine. “We remain committed to doing everything that we can to ending this ongoing pandemic with our mRNA COVID-19 vaccine.” The company said the doses were offered “at Moderna’s lowest tiered price, in line with the company’s global access commitments,” without specifying. Gavi’s rush to get vaccines to poorer countries — particularly in light of the delays in supply from India — got a boost when Sweden’s government announced plans to donate 1 million doses of AstraZeneca vaccines through COVAX.

India Pandemic Sweden Vaccines Countries Million Vaccine Program Doses Gavi Covax Inks Moderna  starting  million  india  doses  covax  deal  vaccines  q4  vaccine  program  500m  countries  pandemic  inks  moderna

History of this topic

Global vaccine alliance GAVI to buy 500,000 doses of mpox vaccine
3 months, 3 weeks ago

Global vaccine alliance GAVI to buy 500,000 doses of mpox vaccine

Associated Press  

DAKAR, Senegal — The global vaccine alliance Gavi will buy 500,000 doses of mpox vaccine to battle outbreaks of the disease in African countries, the organization said on Wednesday. Since the beginning of the year, there have been over 25,000 confirmed mpox cases and 723 related deaths, the vast majority in Congo, and the World Health Organization declared it a …

Global vaccine alliance GAVI to buy 500,000 doses of mpox vaccine
3 months, 3 weeks ago

Global vaccine alliance GAVI to buy 500,000 doses of mpox vaccine

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy The global vaccine alliance Gavi …

US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine
55 years ago

US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine

Wired  

The US government will pay Moderna $176 million to develop an mRNA vaccine against a pandemic influenza—an award given as the highly pathogenic bird flu virus H5N1 continues to spread widely among US dairy cattle. In its own announcement on Tuesday, Moderna noted that it began a Phase 1/2 trial of a pandemic influenza virus vaccine last year, which included …

Anticipating a major bird flu crisis, the U.S. government just awarded $176 million for a vaccine
6 months, 1 week ago

Anticipating a major bird flu crisis, the U.S. government just awarded $176 million for a vaccine

Salon  

In the ongoing waves of bird flu outbreaks, with the virus spreading to more than 141 herds in 12 states, the risk of another full-blown pandemic like COVID-19 is becoming a distinct possibility. In preparation for just such a disaster, the U.S. government will pay pharmaceutical company Moderna $176 million to develop a vaccine that protects against the H5N1 virus. …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
8 months ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

AstraZeneca pulls its COVID-19 vaccine from the European market
8 months ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand
8 months ago

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand

ABC  

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine due to …

UN approves an updated cholera vaccine that could help fight a surge in cases
8 months, 3 weeks ago

UN approves an updated cholera vaccine that could help fight a surge in cases

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy The World Health Organization has …

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data
1 year ago

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data

The Hindu  

A total of 220.67 crore COVID vaccine doses have been administered across the country as on December 21 this year, according to data released by the Health Ministry on Wednesday. However, only 22.88 crore precautionary or booster doses have been administered across the country among the eligible adult population. Despite the recent increase of people infected with the JN.1 COVID …

Novavax’s COVID-19 vaccine gets the green light from the FDA, giving third option for protection
1 year, 3 months ago

Novavax’s COVID-19 vaccine gets the green light from the FDA, giving third option for protection

Salon  

On Tuesday, the Food and Drug Administration authorized the use of a new Novavax vaccine specifically targeted to protect against the latest Omicron circulating strains. Following a bumpy rollout of the Moderna and Pfizer vaccines, it will bring another option to the table for those who are ready to roll up their sleeves and get vaccinated amid a rise in …

Updated COVID vaccines will be available later this week, recommended for everyone six months and up
1 year, 3 months ago

Updated COVID vaccines will be available later this week, recommended for everyone six months and up

Salon  

A new, fourth round of COVID-19 booster shots was approved Tuesday, following the recommendation of federal health agencies, which will make the vaccines available to Americans later this week. The Centers for Disease Control and Prevention followed suit this afternoon, with CDC director Mandy Cohen recommending updated vaccination for "everyone 6 months and older to better protect you and your …

Should you get the new COVID booster? The CDC is about to decide
1 year, 3 months ago

Should you get the new COVID booster? The CDC is about to decide

LA Times  

A nurse prepares a syringe of a COVID-19 vaccine. The CDC’s vaccine advisors will soon decide whether to recommend the latest COVID-19 boosters only for frail, older, sick and immunocompromised people or to offer it to everyone over 6 months of age. “I don’t plan to get it myself,” said Dr. Paul Offit, the director of the Vaccine Education Center …

New Covid vaccines are on the way as 'Eris' variant rises
1 year, 4 months ago

New Covid vaccines are on the way as 'Eris' variant rises

Firstpost  

Some public health experts hope that Americans will welcome the new shot as they would a flu jab. But demand for the vaccine has dropped sharply since 2021 when it first became available and more than 240 million people in the U.S., or 73% of the population, received at least one shot A new COVID vaccine is due out next …

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose
1 year, 6 months ago

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose

The Hindu  

India’s first indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus will cost ₹2,292, Sanjay Singh, CEO, Gennova Biopharmaceuticals, said at a press conference on June 24. The vaccine will for now only be available as a booster or “precaution dose”, that is, somebody who has already been vaccinated thrice will be ineligible as the relevant …

Can a new vaccine rollout change this beaten down pharma MNC's fortune in 2023?
1 year, 8 months ago

Can a new vaccine rollout change this beaten down pharma MNC's fortune in 2023?

Live Mint  

It's tough being a pharma company these days.the pharma sector, which once used to be the star of the street, has been witnessing bad times since 2022. Over the last few years, the company has underperformed relative to its peers due to a series of challenges, including oncology clinical failures and missing out on the lucrative market for the first …

Serum Institute of India to produce 5mn Covishield doses in two months
1 year, 8 months ago

Serum Institute of India to produce 5mn Covishield doses in two months

Hindustan Times  

Serum Institute of India chief executive officer Adar Poonawalla, while underlining that the current strain of Covid is mild and the demand for vaccine shots is low, said his firm will produce five to six million Covishield doses in the next two to three months and same amount of stock is already available for Covovax. According to Poonawalla, SII has …

WATCH: SII chief Adar Poonawalla on vaccine availability, current Covid strain
1 year, 8 months ago

WATCH: SII chief Adar Poonawalla on vaccine availability, current Covid strain

Hindustan Times  

Commenting on the recent spike in Covid cases countrywide, Serum Institute of India chief executive officer Adar Poonawalla on Saturday said that the current variant of the virus is not severe and five to six million doses of Covovax are available. We will also produce the same amount of Covishield doses in the next two to three months,” news agency …

Covovax to be available on CoWIN as booster dose soon. Check details
1 year, 8 months ago

Covovax to be available on CoWIN as booster dose soon. Check details

Hindustan Times  

In view of rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute’s Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday. According to an official source, Singh had mentioned in his letter to the ministry that …

Moderna expects to price its COVID vaccine at about $130 in the US
1 year, 9 months ago

Moderna expects to price its COVID vaccine at about $130 in the US

Live Mint  

Moderna Inc expects to price its COVID-19 vaccine at around $130 per dose in the U.S. going forward as purchases move to the private sector from the government, the company’s president Stephen Hoge said in an interview on Monday. “There are different customers negotiating different prices right now, which is why it's a little bit complicated,” Hoge said ahead of …

Sliding vaccine sales, new costs, squeeze Moderna 4Q profit
1 year, 10 months ago

Sliding vaccine sales, new costs, squeeze Moderna 4Q profit

Associated Press  

Moderna’s fourth-quarter profit tumbled 70% as COVID-19 vaccine sales fell and the drugmaker caught up on a royalty payment. Heavy research and development costs also weighed on Moderna as the vaccine developer looks to strengthen an income statement currently dominated by its Spikevax coronavirus preventive shots. Researchers are testing how Moderna’s potential vaccine and Merck’s immunotherapy Keytruda work in improving …

Column: Moderna and Pfizer are jacking up the price of COVID vaccines. The government should stop them
1 year, 11 months ago

Column: Moderna and Pfizer are jacking up the price of COVID vaccines. The government should stop them

LA Times  

Doses of the Moderna COVID-19 vaccine wait to be administered at a clinic. That included a research grant of almost $1 billion from the government’s Biomedical Advanced Research and Development Authority, or BARDA, through 2020, plus a $1.5-billion federal purchase guarantee in 2020 for COVID vaccines before testing was even completed — a deal that materially reduced Moderna’s financial risks …

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose
1 year, 11 months ago

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

News 18  

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had recently written to the DCGI for the approval …

COVID-19: Covovax vaccine to get approval as booster dose in 10-15 days, says Poonawalla
2 years ago

COVID-19: Covovax vaccine to get approval as booster dose in 10-15 days, says Poonawalla

Firstpost  

Pune: Chief Executive Officer of Serum Institute of India, Adar Poonawalla, has said their Covovax vaccine will get approval as a booster dose against Covid-19 in the next 10 to 15 days. Poonawalla told the media that the vaccine works very well against the Omicron variant of coronavirus. Speaking to reporters on the sidelines of an event at the Bharati …

Covovax vaccine will get approval in next 10-15 days, says SII CEO Poonawalla
2 years ago

Covovax vaccine will get approval in next 10-15 days, says SII CEO Poonawalla

Hindustan Times  

Chief Executive Officer of Serum Institute of India, Adar Poonawalla, has said their Covovax vaccine will get approval as a booster dose against Covid-19 in the next 10 to 15 days. Adar Poonawalla, chief executive officer of Serum Institute of India Speaking to reporters on the sidelines of an event at the Bharati Vidyapeeth University here on Sunday, the SII …

Covovax to get approval as booster in 10-15 days, says SII’s Adar Poonawalla
2 years ago

Covovax to get approval as booster in 10-15 days, says SII’s Adar Poonawalla

Live Mint  

As India braces for a possible rise in COVID-19 cases, a new vaccine is set to join the ranks as booster this month. Serum Institute of India's Covovax vaccine - which is effective against the Omicron strains - will get approval as a booster jab against COVID-19 in the next 10 to 15 days. All you need to know about …

Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch
2 years ago

Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch

Hindustan Times  

Around 250 million Covid vaccines manufactured by two major Hyderabad-based units – Biological E and Bharat Biotech – are ready for dispatch in the market as soon as orders are received. Nearly 200 million Corbevax vaccine of Biological E and 50 million of Bharat Biotech's Covaxin are stockpiled at the moment. Read| Covid drills at hospitals; case count remains low …

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses
2 years ago

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses

India TV News  

As Covid cases are increasing in the country, now focus is back on vaccination drive. According to sources- two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together have about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received. Corbevax and Covaxin stocks Biological E held 200 million doses of its …

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose
2 years ago

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose

News 18  

The Serum Institute of India has sought the drug regulator’s approval for market authorisation of its COVID-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for …

Covid vaccines have averted THREE MILLION deaths in America
2 years ago

Covid vaccines have averted THREE MILLION deaths in America

Daily Mail  

Two years ago tomorrow the first person in the US got the shot outside a trial The report likely underestimates the full impact of vaccines, the researchers said More than 120 million Covid infections were prevented by the shots, it found Covid vaccines have averted more than three million deaths in the US during the pandemic, a report has found. …

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget
2 years, 2 months ago

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget

The Hindu  

The government’s COVID-19 vaccination programme is in its final leg with the Health Ministry deciding against procuring more vaccines as of now and surrendering ₹4,237 crore, or nearly 85% of the 2022-23 budget allocation for inoculation purposes, to the Finance Ministry. Official sources told PTI that more than 1.8 crore doses are still available with the governments at the Centre …

Covid-19: India logs nearly 5,000 new infections, active cases drop below 45k
2 years, 3 months ago

Covid-19: India logs nearly 5,000 new infections, active cases drop below 45k

Live Mint  

India has witnessed a marginal decline in daily Covid-19 cases on Saturday with country recording 4,912 new infections in the past 24 hours, according to an update given by the Ministry of Health and Family Welfare. The country conducted 3,03,888 Covid tests in the last 24 hours, with the total number of tests conducted so far at 89.33 crore. The …

GAVI financing to allow for immediate funds for next pandemic
2 years, 3 months ago

GAVI financing to allow for immediate funds for next pandemic

Live Mint  

Global vaccine alliance GAVI has set up financial instruments that will allow the group to immediately access pledged donor funding if it needs to buy vaccines for future pandemics, Chief Executive Seth Berkley told Reuters. Berkley said that in 2020 and 2021, GAVI was limited in its ability to buy COVID-19 vaccines because even though donors had committed $2.4 billion, …

New vaccines approved, booster campaign to start in September
2 years, 4 months ago

New vaccines approved, booster campaign to start in September

Dutch News  

The new Pfizer and Moderna booster vaccines have been given approval by the European Medicines Agency for over-12s, and another booster campaign is planned for the second half of September. Although the current vaccines protect against serious sickness, they have become less good at protecting against a coronavirus infection due to mutations in the virus, reports NOS. The EMA expects …

New vaccines approved, booster campaign to start in September
2 years, 4 months ago

New vaccines approved, booster campaign to start in September

Dutch News  

The new Pfizer and Moderna booster vaccines have been given approval by the European Medicines Agency for over-12s, and another booster campaign is planned for the second half of September. Although the current vaccines protect against serious sickness, they have become less good at protecting against a coronavirus infection due to mutations in the virus, reports NOS. The EMA expects …

Serum Institute Will Try to Launch Omicron-specific Covid-19 Vaccine After Six Months, Says Adar Poonawalla
2 years, 4 months ago

Serum Institute Will Try to Launch Omicron-specific Covid-19 Vaccine After Six Months, Says Adar Poonawalla

News 18  

The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday. “The original Novovax vaccine Covovax covers omicron and there is good data for it. We will try to launch Omicron-specific vaccine after six months,” he said. The Pune-based Serum Institute is working with US biotechnology major Novavax …

Tackling the new variants
2 years, 4 months ago

Tackling the new variants

Hindustan Times  

The first redesigned coronavirus vaccine was approved for use this week when authorities in the United Kingdom cleared a Moderna dose that the company adapted to create immunity against the Omicron variant. The vaccine is a 50-50 formulation of Moderna’s 2020 product, designed on the Sars-CoV-2 variant that first spread around the world, and of a new dose developed using …

Corbevax Likely to be Available As Covid Booster Dose at Vaccination Centres from Friday
2 years, 4 months ago

Corbevax Likely to be Available As Covid Booster Dose at Vaccination Centres from Friday

News 18  

Biological E. Ltd on Thursday said it has delivered 10 crore doses of its Covid-19 vaccine, Corbevax to the Centre so far which is expected to be available as a booster dose on the Cowin App in public and private vaccination centers from Friday. Corbevax was also approved by the Union Health Ministry as a heterologous Covid-19 booster dose under …

COVID-19: Over 7.20 crore unutilized vaccine doses available with States, Union Territories says health ministry
2 years, 5 months ago

COVID-19: Over 7.20 crore unutilized vaccine doses available with States, Union Territories says health ministry

Firstpost  

The vaccination drive has been ramped up through the availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain New Delhi: The Ministry of Health and Family Welfare on Sunday informed that more than 7.20 crore balance and unutilized COVID-19 vaccine doses are still available …

In race for monkeypox vaccines, experts see repeat of COVID-19
2 years, 5 months ago

In race for monkeypox vaccines, experts see repeat of COVID-19

The Hindu  

Moves by rich countries to buy large quantities of monkeypox vaccine, while declining to share doses with Africa, could leave millions of people unprotected against a more dangerous version of the disease and risk continued spillovers of the virus into humans, public health officials are warning. Yet while monkeypox is much harder to spread than COVID-19, experts warn that if …

India's Covid Vaccinations Hit 200 Crore Mark in Big Milestone for 7-Phase Drive Under Modi's Leadership
2 years, 5 months ago

India's Covid Vaccinations Hit 200 Crore Mark in Big Milestone for 7-Phase Drive Under Modi's Leadership

News 18  

India has crossed record 200 crore mark in Covid-19 vaccinations within 18 months of launching the inoculation exercise in January last year. #200CroreVaccinations https://t.co/FtobFYBprV— Dr Mansukh Mandaviya July 17, 2022 A seven-phase vaccination drive was followed on the principle of Prioritization for Vaccine Administration based on scientific advice and global best practices, government officials told News18. While some experts had …

US regulators OK new COVID-19 shot option from Novavax
2 years, 5 months ago

US regulators OK new COVID-19 shot option from Novavax

Associated Press  

The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults. Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S. -- and one that’s already available in Europe and multiple other countries. Novavax also has submitted data on booster …

Free booster shots for adults at government hospitals from Friday
2 years, 5 months ago

Free booster shots for adults at government hospitals from Friday

Deccan Chronicle  

NEW DELHI: In a major move to expand the coverage of booster dose for Covid-19, the Central government on Wednesday announced that precautionary jab will now be made available free of cost for all individuals above 18 years of age at all government vaccination centres. The minister said that free booster dose drive is being held for the next 75 …

COVID-19: US FDA authorises Novavax vaccine for emergency use in adults
2 years, 5 months ago

COVID-19: US FDA authorises Novavax vaccine for emergency use in adults

India TV News  

Highlights US regulators OK new COVID-19 shot option from Novavax vaccine Food and Drug Administration on Wednesday cleared Novavax shots for adults in US Novavax makes more traditional type of shot than three other COVID vaccines available for use in US COVID-19 news : The US is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday …

Serum Institute gets govt nod to export 32.4 lakh doses of Covovax vaccine to US
2 years, 6 months ago

Serum Institute gets govt nod to export 32.4 lakh doses of Covovax vaccine to US

India Today  

The government has allowed Serum Institute of India to supply 32.4 lakh doses of its Covid-19 jab Covovax under the brand name Nuvaxovid to the US, which will be the first vaccine to be exported to the country by any Indian manufacturer, official sources said on Friday. "It is a matter of pride for us and our country that, in …

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study
2 years, 6 months ago

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study

The Hindu  

COVID-19 vaccines prevented over 42 lakh potential deaths in India in 2021, said a study published in The Lancet Infectious Diseases journal, which based its findings on estimates of "excess" mortalities in the country during the pandemic. In the first year of the vaccination programme, 19.8 million out of a potential 31.4 million COVID-19 deaths were prevented worldwide, according to …

US Panel Recommends Moderna Covid Vaccine for Children Six and Up
2 years, 6 months ago

US Panel Recommends Moderna Covid Vaccine for Children Six and Up

News 18  

A panel of US medical experts on Tuesday recommended the Moderna Covid vaccine for use in children aged six through 17. Formal authorization should soon follow, at which point families will have a second option against the coronavirus, as Pfizer’s vaccine was given the greenlight for teens and younger children last year. After weighing available data, 22 experts convened by …

Biden administration lays out its plan for Covid-19 vaccinations for children under 5
2 years, 7 months ago

Biden administration lays out its plan for Covid-19 vaccinations for children under 5

CNN  

CNN — The White House has announced a highly anticipated Covid-19 vaccine rollout plan for children under 5. The administration “has made 10 million vaccine doses available for states, Tribes, territories, community health centers, federal pharmacy partners, and others to pre-order,” according to a White House fact sheet shared with CNN Wednesday. “Our experience is that the longer the ordering …

FDA advisory panel gives near-unanimous recommendation to Novavax's COVID-19 vaccine
2 years, 7 months ago

FDA advisory panel gives near-unanimous recommendation to Novavax's COVID-19 vaccine

Daily Mail  

Novavax's COVID-19 vaccine received near-unanimous approval for use in adults over 18 years old on Tuesday, paving the way for it to become the fourth jab and first protein-based shot to be rolled out in America. Unlike Pfizer and Moderna's shots, the Novavax jab uses the same protein-based technology as flu vaccines, which expose the immune system to spike proteins …

Novavax hopes its COVID shot wins over FDA, vaccine holdouts
2 years, 7 months ago

Novavax hopes its COVID shot wins over FDA, vaccine holdouts

Associated Press  

— Americans may soon get a new COVID-19 vaccine option -- shots made with a more tried-and-true technology than today’s versions. “What I’ve seen of the Novavax data so far is it’s a really impressive protein vaccine,” said University of Pennsylvania immunologist E. John Wherry. Novavax, a small biotech company, created the vaccine in its research lab, but the Serum …

Moderna Delays Covid Vaccine Deliveries to EU by Several Months
2 years, 7 months ago

Moderna Delays Covid Vaccine Deliveries to EU by Several Months

News 18  

Moderna Inc said on Thursday it has agreed to push back some COVID-19 vaccine deliveries to the European Union by several months to later in 2022 or early next year. The bloc had also tweaked agreements with Pfizer Inc and German partner BioNTech SE in April to delay vaccine deliveries by three months as it gears up for a potential …

Discover Related